Celastrol is a pentacyclic triterpene compound isolated from Tripterygium wilfordii as a novel treatment for pulmonary fibrosis; it exhibits antifibrotic effects through the covalent linkage of CAND1 at the Cys264 residue. Here, CAND1 is linked to pulmonary fibrosis.